|
2.
|
|
22 p, 3.0 MB |
Involvement of JNK1 in Neuronal Polarization During Brain Development
/
Castro-Torres, Rubén D. (Universidad de Guadalajara. Department of Cell and Molecular Biology) ;
Busquets, Oriol (Universitat Autònoma de Barcelona. Institut de Neurociències) ;
Parcerisas, Antoni (Universitat de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia) ;
Verdaguer, Ester (Universitat de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia) ;
Olloquequi, Jordi (Universidad Autónoma de Chile) ;
Ettcheto, Miren (Universitat Autònoma de Barcelona. Institut de Neurociències) ;
Beas-Zarate, Carlos (Universidad de Guadalajara. Department of Cell and Molecular Biology) ;
Folch, Jaume (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Camins, Antoni (Universitat Autònoma de Barcelona. Institut de Neurociències) ;
Auladell, Carme (Universitat de Barcelona. Departament de Biologia Cel·lular, Fisiologia i Immunologia)
The c-Jun N-terminal Kinases (JNKs) are a group of regulatory elements responsible for the control of a wide array of functions within the cell. In the central nervous system (CNS), JNKs are involved in neuronal polarization, starting from the cell division of neural stem cells and ending with their final positioning when migrating and maturing. [...]
2020 -  10.3390/cells9081897
Cells, Vol. 9 (august 2020)
|
|
|
3.
|
|
19 p, 2.8 MB |
ENIGMA MDD : seven years of global neuroimaging studies of major depression through worldwide data sharing
/
Schmaal, Lianne (The University of Melbourne) ;
Pozzi, Elena (The University of Melbourne) ;
C. Ho, Tiffany (University of California) ;
van Velzen, Laura S. (The University of Melbourne) ;
Veer, Ilya M. (Humboldt-Universität zu Berlin) ;
Opel, Nils (University of Münster) ;
Van Someren, Eus J. W. (Vrije Universiteit Amsterdam) ;
Han, L.K.M (Vrije Universiteit Amsterdam) ;
Aftanas, Lybomir (Novosibirsk State University) ;
Aleman, André (University Medical Center Groningen) ;
Baune, Bernhard T. (University of Melbourne) ;
Berger, Klaus (University of Münster) ;
Blanken, Tessa F. (Vrije Universiteit Amsterdam) ;
Capitão, Liliana (Oxford Health NHS Foundation Trust) ;
Couvy-Duchesne, Baptiste (the University of Queensland) ;
R. Cullen, Kathryn (University of Minnesota) ;
Dannlowski, Udo (University of Münster) ;
Davey, Christopher (University of Melbourne) ;
Erwin-Grabner, Tracy (University Medical Center Göttingen) ;
Evans, Jennifer (Experimental Therapeutics Branch, NIMH, NIH, Bethesda, MD USA) ;
Frodl, Thomas (Jena University Hospital (Alemanya)) ;
Fu, Cynthia H. Y. (King's College London) ;
Godlewska, Beata (Oxford University) ;
Gotlib, Ian H. (Stanford University) ;
Goya-Maldonado, Roberto (University Medical Center Göttingen) ;
Grabe, Hans J. (German Center for Neurodegenerative Diseases) ;
Groenewold, Nynke A. (University of Cape Town) ;
Grotegerd, Dominik (University of Münster) ;
Gruber, Oliver (Heidelberg University Hospital (Alemanya)) ;
Gutman, Boris A. (Illinois Institute of Technology) ;
Hall, Geoffrey B. (McMaster University (Canadà)) ;
Harrison, Ben J. (The University of Melbourne & Melbourne Health) ;
Hatton, Sean N. (University of Sydney) ;
Hermesdorf, Marco (University of Münster) ;
Hickie, Ian B. (University of Sydney) ;
Hilland, Eva (University of Oslo.) ;
Irungu, Benson (The University of Texas) ;
Jonassen, Rune (Oslo Metropolitan University) ;
Kelly, Sinead (Harvard Medical School, Boston, MA USA) ;
Kircher, Tilo (University of Marburg) ;
Klimes-Dougan, Bonnie (University of Minnesota) ;
Krug, Axel (University of Marburg) ;
Landrø, Nils Inge (Diakonhjemmet Hospital) ;
Lagopoulos, Jim (University of the Sunshine Coast) ;
Leerssen, Jeanne (Vrije Universiteit Amsterdam) ;
Li, Meng (Jena University Hospital (Alemanya)) ;
Linden, David E. J. (Cardiff University) ;
MacMaster, Frank P. (University of Calgary) ;
McIntosh, Andrew M.. (University of Edinburgh) ;
Mehler, David M. A. (Cardiff University) ;
Nenadić, Igor (Marburg University Hospital UKGM, Marburg, Germany) ;
Penninx, Brenda W. J. H. (Vrije Universiteit Amsterdam) ;
Portella, Maria J.. (Institut d'Investigació Biomèdica Sant Pau) ;
Reneman, Liesbeth (location AMC, Amsterdam UMC) ;
Rentería, Miguel E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ;
Sacchet, Matthew D. (Harvard Medical School) ;
G. Sämann, Philipp (Max Planck Institute of Psychiatry) ;
Schrantee, Anouk (location AMC, Amsterdam UMC) ;
Sim, Kang (National University of Singapore) ;
Soares, Jair C. (The University of Texas) ;
Stein, Dan J. (University of Cape Town) ;
Tozzi, Leonardo (Stanford University) ;
van Der Wee, Nic J. A. (Leiden University Medical Center) ;
van Tol, Marie-José (University of Groningen) ;
Vermeiren, Robert (Leiden University Medical Center) ;
Vives-Gilabert, Yolanda (Universitat Politècnica de València) ;
Walter, Henrik (Humboldt-Universität zu Berlin) ;
Walter, Martin (Leibniz Institute for Neurobiology) ;
Whalley, Heather (University of Edinburgh) ;
Wittfeld, Katharina (German Center for Neurodegenerative Diseases) ;
Whittle, Sarah (The University of Melbourne) ;
Wright, Margaret J. (The University of Queensland) ;
Yang, Tony T. (University of California) ;
Zarate, Carlos (National Institute of Mental Health, Bethesda, MD, USA) ;
Thomopoulos, Sophia I. (University of Southern California) ;
Jahanshad, Neda (University of Southern California) ;
Thompson, Paul M. (University of Southern California) ;
Veltman, Dick J. (Vrije Universiteit Amsterdam) ;
Universitat Autònoma de Barcelona
A key objective in the field of translational psychiatry over the past few decades has been to identify the brain correlates of major depressive disorder (MDD). Identifying measurable indicators of brain processes associated with MDD could facilitate the detection of individuals at risk, and the development of novel treatments, the monitoring of treatment effects, and predicting who might benefit most from treatments that target specific brain mechanisms. [...]
2020 - 10.1038/s41398-020-0842-6
Translational psychiatry, Vol. 10 (may 2020)
|
|
|
4.
|
|
18 p, 1.4 MB |
Experimental Models for Aging and their Potential for Novel Drug Discovery
/
Folch, Jaume (Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut) ;
Busquets, Oriol (Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut) ;
Ettcheto, Miren (Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut) ;
Sánchez-López, Elena (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Pallàs, Mercè (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Beas-Zarate, Carlos (Departamento de Biologia Celulary Molecular, C.U.C.B.A., Universidad de Guadalajara and Division de Neurociencias, Sierra Mojada 800, Col. Independencia, Guadalajara, Jalisco 44340, Mexico.) ;
Marin, Miguel (Centro de Biotecnologia. Universidad Nacional de Loja, Av. Pío Jaramillo Alvarado y Reinaldo Espinosa, La Argelia. Loja, Ecuador.) ;
Casadesus, Gemma (Department of Biological Sciences, Kent State University, Kent, OH, United States.) ;
Olloquequi, Jordi (Universidad Autonoma de Chile. Facultad de Ciencias de la Salud) ;
Auladell, Carme (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Camins, Antoni (Universitat de Barcelona. Departament de Farmacologia, Toxicologia i Química Terapèutica)
An interesting area of scientific research is the development of potential antiaging drugs. In order to pursue this goal, it is necessary to gather the specific knowledge about the adequate preclinical models that are available to evaluate the beneficial effects of new potential drugs. [...]
2018 - 10.2174/1570159X15666170707155345
Current neuropharmacology, Vol. 16 (december 2018) , p. 1466-1483
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
